NorelCSCS (US Pharmaceutical Corporation)


Welcome to the PulseAid listing for the NorelCS drug offered from US Pharmaceutical Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: US Pharmaceutical Corporation
NON-PROPRIETARY NAME: Chlorpheniramine Maleate/Dextromethorphan Hydrobromide/Phenylephrine Hydrochloride
SUBSTANCE NAME: CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2012-08-01
END MARKETING DATE: 0000-00-00


NorelCS CS HUMAN OTC DRUG Details:

Item DescriptionNorelCS CS from US Pharmaceutical Corporation
LABELER NAME: US Pharmaceutical Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 12.5; 10(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2012-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52747-480_51fa1666-3a2d-401c-afc2-85641bd92258
PRODUCT NDC: 52747-480
APPLICATION NUMBER: part341

Other CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Advanced Generic CorporationBIO-RYTUSS
EDWARDS PHARMACEUTICALS, INC.ED-A-HIST DM
KRAMER NOVISGENCONTUSS
Laser Pharmaceuticals, LLCDonatussin
Okendpharma, Inc.Rycontuss
Portal PharmaceuticalBronkids
US Pharmaceutical CorporationNorelCS